Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : FMA / FracMaster -- Ignore unavailable to you. Want to Upgrade?

To: Ulster1 who wrote (218)	5/18/1999 5:00:00 PM
From: CharlieChina	Respond to of 233

Agreed...assets or FMA...probably both...he can buy the assets then roll them back into FMA for shares... FMA has a long history in Europe...it has a product name worth something...my guess...with Balm owning 40%...he's got something up his sleeve for FMA...

To: Ulster1 who wrote (218)	5/18/1999 5:11:00 PM
From: jsavage	Read Replies (1) \| Respond to of 233

I'd say he'd buy the assets and start all over as a private entity. He, just like UTI and CALFRAC, is playing a new game now. Who has the most cash? Balm had presented an option under CCAA statutes which required everyones' interest be accounted for in some fashion. Under receivership, he doesn't have that burden to live up to. He is doing what is necessary to "win the bid". UTI's offer was for $60 m, Balms bid was for $97 m including the aid to shareholders and vendors. Now that the shareholder / vendor protection aspect is out of the scenario, Balm is still more than likely good for his offer, he just doesn't have to acknowledge our existence anymore. He probably will still include some sort of package for the vendors because they have something he needs, but the shareholders lost any leverage we had when it left the realm of the CCAA and entered the "receivership zone". Unfortunately, none of the offers will have any residual effect on the shareholders. DAMNIT!!!!